Multicenter prospective validation of PanClaudinAI: An AI for predicting Claudin 18.2 from CT in pancreatic cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers ...
Alliance A092104: A randomized phase 2/3 study of olaparib plus temozolomide versus investigator’s choice for the treatment of patients with advanced uterine leiomyosarcoma after progression on prior ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果